PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025
PacBio (NASDAQ: PACB), a biotechnology company, has scheduled its second quarter 2025 financial results conference call for Thursday, August 7, 2025, at 5:00 PM Eastern Time (2:00 PM Pacific Time). The earnings call will be accessible through a webcast on the company's investor relations website.
Participants can join via webcast or dial in using toll-free (1-888-349-0136) or international (1-412-317-0459) numbers. Those choosing to dial in are advised to join ten minutes before the start time.
PacBio (NASDAQ: PACB), un'azienda biotecnologica, ha programmato la conference call per la presentazione dei risultati finanziari del secondo trimestre 2025 per giovedì 7 agosto 2025 alle 17:00 ora della costa orientale (14:00 ora della costa pacifica). La chiamata sugli utili sarà disponibile tramite webcast sul sito web delle relazioni con gli investitori della società.
I partecipanti possono unirsi via webcast o chiamare utilizzando i numeri gratuiti (1-888-349-0136) o internazionali (1-412-317-0459). Chi sceglie di chiamare è invitato a connettersi dieci minuti prima dell'inizio.
PacBio (NASDAQ: PACB), una empresa biotecnológica, ha programado su conferencia telefónica de resultados financieros del segundo trimestre de 2025 para el jueves 7 de agosto de 2025 a las 5:00 PM hora del Este (2:00 PM hora del Pacífico). La llamada de resultados estará disponible a través de una transmisión en vivo en el sitio web de relaciones con inversionistas de la compañía.
Los participantes pueden unirse mediante la transmisión en vivo o llamar usando los números gratuitos (1-888-349-0136) o internacionales (1-412-317-0459). Se recomienda a quienes llamen que se conecten diez minutos antes del inicio.
PacBio (NASDAQ: PACB)는 생명공학 기업으로, 2025년 2분기 재무실적 컨퍼런스 콜을 2025년 8월 7일 목요일 오후 5시 동부 시간 (서부 시간 오후 2시)에 예정하고 있습니다. 실적 발표 콜은 회사 투자자 관계 웹사이트를 통해 웹캐스트로 제공됩니다.
참석자는 웹캐스트로 참여하거나 무료 전화번호(1-888-349-0136) 또는 국제 전화번호(1-412-317-0459)를 통해 전화로 참여할 수 있습니다. 전화 참여자는 시작 10분 전에 접속하는 것이 권장됩니다.
PacBio (NASDAQ : PACB), une entreprise de biotechnologie, a programmé sa conférence téléphonique sur les résultats financiers du deuxième trimestre 2025 pour le jeudi 7 août 2025 à 17h00 heure de l'Est (14h00 heure du Pacifique). La conférence téléphonique sera accessible via un webcast sur le site des relations investisseurs de la société.
Les participants peuvent rejoindre via webcast ou téléphoner en utilisant les numéros gratuits (1-888-349-0136) ou internationaux (1-412-317-0459). Il est conseillé à ceux qui appellent de se connecter dix minutes avant le début.
PacBio (NASDAQ: PACB), ein Biotechnologieunternehmen, hat seine Telefonkonferenz zu den Finanzergebnissen des zweiten Quartals 2025 für Donnerstag, den 7. August 2025, um 17:00 Uhr Eastern Time (14:00 Uhr Pacific Time) angesetzt. Der Gewinnanruf wird über einen Webcast auf der Investor-Relations-Website des Unternehmens zugänglich sein.
Teilnehmer können per Webcast teilnehmen oder über gebührenfreie Nummern (1-888-349-0136) bzw. internationale Nummern (1-412-317-0459) einwählen. Teilnehmer, die sich einwählen, werden gebeten, zehn Minuten vor Beginn beizutreten.
- None.
- None.
MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on Thursday, August 7, 2025, at 5:00 pm Eastern Time.
The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/.
Date: Thursday, August 7, 2025, at 5:00 pm ET (2:00 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
If using the dial-in option, please join the call ten minutes before the start time using the appropriate number above and ask to join the “PacBio Q2 Earnings Call.”
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When will PacBio (NASDAQ: PACB) report Q2 2025 earnings?
How can investors access PacBio's Q2 2025 earnings call?
What time should investors dial in for PacBio's Q2 earnings call?
Where can I find the replay of PacBio's Q2 2025 earnings call?
